Medical AI Still Lacks Proof
2026-09-18
Medical AI has a proof problem: strong benchmark scores still fail to produce large gains at the bedside. The gap is stubborn. In controlled datasets, a model can spot patterns with high sensitivity, yet its apparent accuracy may sag when prevalence, imaging protocols, and patient mix change beyond the development sample. This is distribution shift, not bad luck. A clinic is not a leaderboard.
The industry has mistaken prediction for care, as though a diagnostic signal were a prescription rather than one input in a crowded decision. That error matters. Retrospective validation can show that software recognized a pattern after the fact, but prospective trials must show that clinicians changed decisions and patients received better outcomes. They are harder. Such studies must account for alert fatigue, staffing limits, electronic records, and calibration, because a well-tuned model in one hospital can mislead in another.
The real measure is humbler: did the tool reduce missed disease, shorten harmful delays, or spare patients an unnecessary test? That is the test. Hospitals should demand external validation and evidence of clinical utility before treating an algorithm as infrastructure. Otherwise, medicine may acquire another bright screen that reports risk with confidence while care remains unchanged.
Loading...
